You are here
- Home
- Therapy Areas
- Cardiovascular
A Randomised, Double-blind, Double-dummy, Parallel Group, International (Asian), Multicenter, Phase 3 Study to Assess Safety and Efficacy of AZD6140 on top of low dose Acetyl Salicylic Acid(ASA) versus Clopidogrel on top of low dose ASA in Asian/Japanese Patients with Non-ST or ST Elevation Acute Coronary Syndromes(ACS) for whom PCI is planned
- Disease
- acute coronary syndrome
- Drug Name
- Brilinta
- Generic Name
- Ticagrelor
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IIIb
- Start Date
- Feb 28, 2011
- Study Name
- D5130C00027
- Study Id
- D5130C00027
- ClinicalTrials.gov ID
- NCT01294462
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
